Evidence map›Paper›PMID 30790144›Full record

ArticleEJNMMI research2019

Nadia Benabdallah, Michela Bernardini, Marta Bianciardi, Claire de Labriolle-Vaylet, Didier Franck, Aurélie Desbrée

Open access · goldAbstract read
In one paragraph

Article in EJNMMI research, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
3.1field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 32 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. A Projection-Domain Low-Count Quantitative SPECT Method forIEEE transactions on radiation and plasma medical sciences · 2023
    Article
  7. Compton imaging for medical applications.Radiological physics and technology · 2022
    Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Prostate Cancer Theranostics - An Overview.Frontiers in oncology · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 2 countries.

Nadia BenabdallahInternal Dose Assessment Laboratory, Institute for Radiological Protection and Nuclear Safety (IRSN), Fontenay-aux-Roses, France. benabdallah.nadia@live.fr.ORCID http://orcid.org/0000-0002-1511-6693
Michela BernardiniNuclear Medicine Department, European Hospital George Pompidou (HEGP), Paris, France.
Marta BianciardiDepartment of Radiology, Athinoula A. Martinos Center for Biomedical Imaging, Massachusetts General Hospital and Harvard Medical School, Boston, USA.
Claire de Labriolle-VayletUPMC, Univ Paris 06 Biophysics, Paris, France.
Didier FranckInternal Dose Assessment Laboratory, Institute for Radiological Protection and Nuclear Safety (IRSN), Fontenay-aux-Roses, France.
Aurélie DesbréeInternal Dose Assessment Laboratory, Institute for Radiological Protection and Nuclear Safety (IRSN), Fontenay-aux-Roses, France.
Institut de Radioprotection et de Sûreté Nucléaire · FRHarvard University · USHôpital Européen Georges-Pompidou · FRSorbonne Université · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

background

resultsExperiences showed that the 85 keV ± 20%, 154 keV ± 10%, and 270 keV ± 10% energy windows are the most suitable for

conclusionsAbsolute quantitative

Indexed as

223RaBone metastasisPhysical phantomsQuantitative imagingRadionuclide therapySPECT imaging

Identifiers

PMID30790144
PMCPMC6384291
OpenAlexW2938724659

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.